|
|
|
Volumn 27, Issue 3, 2007, Pages 256-257
|
|
What happened to the Provenge (Sipuleucel-T) vaccine for hormone refractory prostate cancer?
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CANCER VACCINE;
SIPULEUCEL T;
SIPULEUCEL-T;
TISSUE EXTRACT;
UNCLASSIFIED DRUG;
ARTICLE;
CLINICAL TRIAL;
DRUG APPROVAL;
FOOD AND DRUG ADMINISTRATION;
HEALTH SERVICE;
HUMAN;
MALE;
ORGANIZATION AND MANAGEMENT;
PROSTATE TUMOR;
UNITED STATES;
CANCER VACCINES;
CLINICAL TRIALS;
DRUG APPROVAL;
HEALTH SERVICES NEEDS AND DEMAND;
HUMANS;
MALE;
PROSTATIC NEOPLASMS;
TISSUE EXTRACTS;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
|
EID: 34548751834
PISSN: 1053816X
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (3)
|
|
References (0)
|
